SE9501384D0 - Process for the preparation of respirable particles - Google Patents

Process for the preparation of respirable particles

Info

Publication number
SE9501384D0
SE9501384D0 SE9501384A SE9501384A SE9501384D0 SE 9501384 D0 SE9501384 D0 SE 9501384D0 SE 9501384 A SE9501384 A SE 9501384A SE 9501384 A SE9501384 A SE 9501384A SE 9501384 D0 SE9501384 D0 SE 9501384D0
Authority
SE
Sweden
Prior art keywords
preparation
solvent
inhalation
respirable particles
compound
Prior art date
Application number
SE9501384A
Other languages
English (en)
Inventor
Edib Jakupovic
Jan Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20397958&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9501384(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9501384A priority Critical patent/SE9501384D0/sv
Publication of SE9501384D0 publication Critical patent/SE9501384D0/sv
Priority to SA96160645A priority patent/SA96160645B1/ar
Priority to ZA962596A priority patent/ZA962596B/xx
Priority to TW085103802A priority patent/TW492877B/zh
Priority to IN723DE1996 priority patent/IN185119B/en
Priority to IL11784196A priority patent/IL117841A/en
Priority to NZ305515A priority patent/NZ305515A/xx
Priority to EP96910285A priority patent/EP0820276B1/en
Priority to AT96910285T priority patent/ATE230257T1/de
Priority to DK96910285T priority patent/DK0820276T3/da
Priority to CN96194372A priority patent/CN1102383C/zh
Priority to PCT/SE1996/000479 priority patent/WO1996032095A1/en
Priority to AR33616796A priority patent/AR001624A1/es
Priority to PT96910285T priority patent/PT820276E/pt
Priority to ES96910285T priority patent/ES2188750T3/es
Priority to CA002217062A priority patent/CA2217062A1/en
Priority to AU53524/96A priority patent/AU694863B2/en
Priority to JP8530963A priority patent/JPH11503448A/ja
Priority to US08/669,477 priority patent/US6221398B1/en
Priority to DE69625589T priority patent/DE69625589T2/de
Priority to MYPI96001419A priority patent/MY117344A/en
Priority to NO19974557A priority patent/NO316209B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9501384A 1995-04-13 1995-04-13 Process for the preparation of respirable particles SE9501384D0 (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE9501384A SE9501384D0 (sv) 1995-04-13 1995-04-13 Process for the preparation of respirable particles
SA96160645A SA96160645B1 (ar) 1995-04-13 1996-03-04 عملية لتحضير جسيمات صالحه للتنفس
ZA962596A ZA962596B (en) 1995-04-13 1996-04-01 Process for the preparation of respirable particles
TW085103802A TW492877B (en) 1995-04-13 1996-04-01 Process for the preparation of respirable particles
IN723DE1996 IN185119B (sv) 1995-04-13 1996-04-02
IL11784196A IL117841A (en) 1995-04-13 1996-04-08 Process for the preparation of pharmaceutical powder for inhalation
US08/669,477 US6221398B1 (en) 1995-04-13 1996-04-12 Process for the preparation of respirable particles
DE69625589T DE69625589T2 (de) 1995-04-13 1996-04-12 Verfahren zur herstellung einatembarer partikel
DK96910285T DK0820276T3 (da) 1995-04-13 1996-04-12 Fremgangsmåde til fremstilling af respirerbare partikler
PT96910285T PT820276E (pt) 1995-04-13 1996-04-12 Processo para a preparacao de particulas respiraveis
AT96910285T ATE230257T1 (de) 1995-04-13 1996-04-12 Verfahren zur herstellung einatembarer partikel
NZ305515A NZ305515A (en) 1995-04-13 1996-04-12 Preparation of pharmaceutical powder for inhalation using an anti-solvent
CN96194372A CN1102383C (zh) 1995-04-13 1996-04-12 适于吸入使用的颗粒的制备方法
PCT/SE1996/000479 WO1996032095A1 (en) 1995-04-13 1996-04-12 Process for the preparation of respirable particles
AR33616796A AR001624A1 (es) 1995-04-13 1996-04-12 Procedimiento para la preparacion de particulas respirables
EP96910285A EP0820276B1 (en) 1995-04-13 1996-04-12 Process for the preparation of respirable particles
ES96910285T ES2188750T3 (es) 1995-04-13 1996-04-12 Procedimiento para la preparacion de particulas respirables.
CA002217062A CA2217062A1 (en) 1995-04-13 1996-04-12 Process for the preparation of respirable particles
AU53524/96A AU694863B2 (en) 1995-04-13 1996-04-12 Process for the preparation of respirable particles
JP8530963A JPH11503448A (ja) 1995-04-13 1996-04-12 吸引可能粒子の製造法
MYPI96001419A MY117344A (en) 1995-04-13 1996-04-13 Process for the preparation of respirable particles.
NO19974557A NO316209B1 (no) 1995-04-13 1997-10-02 Fremgangsmåte for fremstilling av et farmasöytisk pulver for inhalasjon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501384A SE9501384D0 (sv) 1995-04-13 1995-04-13 Process for the preparation of respirable particles

Publications (1)

Publication Number Publication Date
SE9501384D0 true SE9501384D0 (sv) 1995-04-13

Family

ID=20397958

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9501384A SE9501384D0 (sv) 1995-04-13 1995-04-13 Process for the preparation of respirable particles

Country Status (22)

Country Link
US (1) US6221398B1 (sv)
EP (1) EP0820276B1 (sv)
JP (1) JPH11503448A (sv)
CN (1) CN1102383C (sv)
AR (1) AR001624A1 (sv)
AT (1) ATE230257T1 (sv)
AU (1) AU694863B2 (sv)
CA (1) CA2217062A1 (sv)
DE (1) DE69625589T2 (sv)
DK (1) DK0820276T3 (sv)
ES (1) ES2188750T3 (sv)
IL (1) IL117841A (sv)
IN (1) IN185119B (sv)
MY (1) MY117344A (sv)
NO (1) NO316209B1 (sv)
NZ (1) NZ305515A (sv)
PT (1) PT820276E (sv)
SA (1) SA96160645B1 (sv)
SE (1) SE9501384D0 (sv)
TW (1) TW492877B (sv)
WO (1) WO1996032095A1 (sv)
ZA (1) ZA962596B (sv)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501384D0 (sv) 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
SE9701956D0 (sv) 1997-05-23 1997-05-23 Astra Ab New composition of matter
IL133597A0 (en) * 1997-06-27 2001-04-30 Astra Ab New combination of antiasthma medicaments
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
GB9806477D0 (en) * 1998-03-26 1998-05-27 Glaxo Group Ltd Improved crystals
GB2341120B (en) 1998-09-04 2002-04-17 Aea Technology Plc Controlling uniformity of crystalline precipitates
SE9803770D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Dry powder pharmaceutical formulation
SE9804001D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New process
GB9826284D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826286D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
GB9905512D0 (en) * 1999-03-10 1999-05-05 Smithkline Beecham Plc Process
GB9919693D0 (en) * 1999-08-19 1999-10-20 Rhone Poulenc Rorer Ltd Process
TWI236930B (en) 2000-05-26 2005-08-01 Pfizer Prod Inc Reactive crystallization method to improve particle size
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0016002D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
NZ529258A (en) 2001-05-05 2004-07-30 Accentus Plc Formation of small crystals
DE10137017A1 (de) * 2001-07-30 2003-02-20 Basf Ag Kristallisationsverfahren zur Einstellung kleiner Partikel
US20030049323A1 (en) * 2001-08-29 2003-03-13 Hitt James E. Process to precipitate drug particles
IL160570A0 (en) * 2001-09-26 2004-07-25 Baxter Int Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
WO2003070285A1 (en) * 2002-02-19 2003-08-28 Resolution Chemicals Limited Solvent-based sterilisation of pharmaceuticals
DE10214031A1 (de) * 2002-03-27 2004-02-19 Pharmatech Gmbh Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
FI20020857A (sv) * 2002-05-07 2003-11-08 Focus Inhalation Oy Konversion av amortt material till ett motsvarande kristallint material genom spraytorkning och utnyttjande av det kristallina spraytorkade materialet i läkemedelspreparat
SI1531794T1 (sl) * 2002-06-28 2017-12-29 Civitas Therapeteutics, Inc. Epinefrin za vdihavanje
GB0216700D0 (en) 2002-07-18 2002-08-28 Astrazeneca Ab Process
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040028746A1 (en) * 2002-08-06 2004-02-12 Sonke Svenson Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
US20040028747A1 (en) * 2002-08-06 2004-02-12 Tucker Christopher J. Crystalline drug particles prepared using a controlled precipitation process
CN1694689A (zh) * 2002-09-30 2005-11-09 阿库斯菲尔公司 供吸入的缓释多孔微粒
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
WO2004066912A2 (en) * 2003-01-31 2004-08-12 Technion Research & Development Foundation Ltd. Anti-inflammatory compositions and uses thereof
GB0302673D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
JP5154078B2 (ja) * 2003-02-21 2013-02-27 ザ ユニヴァーシティ オブ バース 粒子の製造プロセス
US7041144B2 (en) * 2003-03-04 2006-05-09 Five Star Technologies, Inc. Hydrodynamic cavitation crystallization process
US7511079B2 (en) * 2003-03-24 2009-03-31 Baxter International Inc. Methods and apparatuses for the comminution and stabilization of small particles
NZ543772A (en) * 2003-04-29 2009-05-31 Organon Nv Antisolvent crystallisation process using membranes for the purification of inorganic or organic compositions
CA2528413A1 (en) * 2003-06-10 2004-12-23 Taisho Pharmaceutical Co., Ltd. Radial spherical crystallization product, process for producing the same and dry powder preparation containing the crystallization product
SE0302029D0 (sv) * 2003-07-07 2003-07-07 Astrazeneca Ab Novel process
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1711163A2 (en) * 2004-02-05 2006-10-18 Baxter International Inc. Dispersions prepared by use of self-stabilizing agents
TWI341836B (en) 2004-03-11 2011-05-11 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
EP1753734A1 (en) * 2004-05-05 2007-02-21 Renopharm Ltd. Nitric oxide donors and uses thereof
US20070231398A1 (en) * 2004-05-05 2007-10-04 Van Lare Cornelis E J Antisolvent Emulsion Solidification Process
US8134010B2 (en) * 2004-05-05 2012-03-13 Renopharm Ltd. Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
US7498445B2 (en) * 2004-05-05 2009-03-03 Renopharm Ltd. Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof
US7968575B2 (en) * 2004-05-05 2011-06-28 Renopharm Ltd. Nitric oxide donors and uses thereof
US20060009435A1 (en) * 2004-06-23 2006-01-12 Joseph Kaspi Synthesis and powder preparation of fluticasone propionate
JP2008510015A (ja) 2004-08-16 2008-04-03 セラヴァンス， インコーポレーテッド β２アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有する化合物
WO2006045795A2 (en) * 2004-10-29 2006-05-04 Akzo Nobel N.V. Processes involving the use of antisolvent crystallization
US20060120972A1 (en) * 2004-11-09 2006-06-08 Peter Engels 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
DE102005011786A1 (de) * 2005-03-11 2006-09-14 Pharmasol Gmbh Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
CN101312713A (zh) * 2005-03-18 2008-11-26 纳米材料科技有限公司 可吸入的药物
WO2006113309A1 (en) 2005-04-15 2006-10-26 Dr. Reddy's Laboratories Ltd. Lacidipine particles
US20060280787A1 (en) * 2005-06-14 2006-12-14 Baxter International Inc. Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
US8475845B2 (en) * 2005-07-15 2013-07-02 Map Pharmaceuticals, Inc. Method of particle formation
CA2615378C (en) * 2005-07-15 2015-02-17 Map Pharmaceuticals, Inc. Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof
EP1909762A2 (en) * 2005-07-28 2008-04-16 Isp Investments Inc. Amorphous efavirenz and the production thereof
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
JP2009516003A (ja) * 2005-11-15 2009-04-16 バクスター・インターナショナル・インコーポレイテッド リポキシゲナーゼ阻害剤の組成物
JP2009519972A (ja) * 2005-12-15 2009-05-21 アキュスフィア， インコーポレイテッド 粒子ベースの経肺投与または経鼻投与用製薬の製造方法
EP1978933A2 (en) * 2005-12-15 2008-10-15 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for oral administration
US7913223B2 (en) * 2005-12-16 2011-03-22 Dialogic Corporation Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
US20080085315A1 (en) * 2006-10-10 2008-04-10 John Alfred Doney Amorphous ezetimibe and the production thereof
WO2008057048A1 (en) * 2006-11-09 2008-05-15 Nanomaterials Technology Pte Ltd Nano & micro-sized particles of statin compounds and process for forming same
WO2008076780A2 (en) * 2006-12-14 2008-06-26 Isp Investments Inc. Amorphous valsartan and the production thereof
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
US20090152176A1 (en) * 2006-12-23 2009-06-18 Baxter International Inc. Magnetic separation of fine particles from compositions
JP5508859B2 (ja) * 2007-01-26 2014-06-04 アイエスピー インヴェストメンツ インコーポレイテッド 噴霧乾燥製品を製造するための調剤処理方法
US20080181961A1 (en) * 2007-01-26 2008-07-31 Isp Investments, Inc. Amorphous oxcarbazepine and the production thereof
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
EP2191821A1 (en) * 2008-11-26 2010-06-02 CHIESI FARMACEUTICI S.p.A. Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation
US8236862B2 (en) * 2009-02-06 2012-08-07 University Of Southern California Therapeutic compositions comprising monoterpenes
US20100291221A1 (en) * 2009-05-15 2010-11-18 Robert Owen Cook Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
US20100298602A1 (en) * 2009-05-19 2010-11-25 Massachusetts Institute Of Technology Systems and methods for microfluidic crystallization
US20100294986A1 (en) * 2009-05-19 2010-11-25 Massachusetts Institute Of Technology Supercritical fluid facilitated particle formation in microfluidic systems
PL2987490T3 (pl) 2009-07-15 2017-12-29 Theravance Biopharma R&D Ip, Llc Postacie krystaliczne wolnej zasady związku bifenylowego
CN102573886A (zh) * 2009-09-17 2012-07-11 相互制药公司 用抗病毒剂治疗哮喘的方法
CN107252488A (zh) * 2009-10-01 2017-10-17 艾戴尔医药公司 口服给予的皮质类固醇组合物
US9889098B2 (en) 2009-10-22 2018-02-13 Vizuri Health Sciences Llc Methods of making and using compositions comprising flavonoids
CA2828833C (en) 2010-03-03 2020-11-03 Neonc Technologies Inc. Pharmaceutical compositions comprising monoterpenes
CN101849910B (zh) * 2010-05-18 2012-02-22 重庆华邦制药股份有限公司 一种二丙酸倍他米松微粒的制备方法
ES2610425T3 (es) 2010-08-27 2017-04-27 Neonc Technologies Inc. Composiciones farmacéuticas que comprenden carbamatos de alcohol perilílico
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
AU2011305566A1 (en) 2010-09-22 2013-05-02 Map Pharmaceuticals, Inc. Aerosol composition for administering drugs
CN103517892B (zh) 2010-12-17 2016-01-27 尼昂克技术公司 使用异紫苏醇的方法和装置
CN102134236B (zh) * 2011-04-15 2013-07-24 北方民族大学 微细克拉霉素粉体的制备方法
AU2012282936B2 (en) * 2011-07-08 2016-11-10 Pfizer Limited Process for the preparation of fluticasone propionate form 1
DK2765994T3 (en) 2011-10-11 2019-03-04 Chiesi Farm Spa Crystalline microparticles of a beta agonist coated with a fatty acid
DE102012221219B4 (de) * 2012-11-20 2014-05-28 Jesalis Pharma Gmbh Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
HUE038899T2 (hu) 2013-03-15 2018-12-28 Verona Pharma Plc Gyógyszer kombináció
ES2682105T3 (es) 2014-05-12 2018-09-18 Verona Pharma Plc Nuevo tratamiento
EP3166595B1 (en) * 2014-07-08 2019-05-15 Amphastar Pharmaceuticals, Inc. Micronized insulin, micronized insulin analogues, and methods of manufacturing the same
KR20170131405A (ko) 2015-02-12 2017-11-29 네온씨 테크놀로지스, 아이엔씨. 페릴릴 알코올 유도체를 포함하는 의약 조성물
US10322168B2 (en) 2016-01-07 2019-06-18 Amphastar Pharmaceuticals, Inc. High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
JP7144411B2 (ja) 2016-11-30 2022-09-29 ネオンク テクノロジーズ インク． ペリリルアルコール－３－ブロモピルベート複合体及びがんの治療方法
CA3225993A1 (en) 2018-02-08 2019-08-15 University Of Southern California The use of monoterpene, sesquiterpene, or their derivatives to permeabilize the blood brain barrier
WO2020205539A1 (en) 2019-03-29 2020-10-08 Vizuri Health Sciences Consumer Healthcare, Inc. Compositions and methods for the prevention and treatment of radiation dermatitis, eczema, burns, wounds and certain cancers
CN114262316A (zh) * 2021-12-24 2022-04-01 嘉应学院 纳米橙皮素、其制备方法及所用双匀浆空化射流***

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
CA1282405C (en) 1984-05-21 1991-04-02 Michael R. Violante Method for making uniformly sized particles from water-insoluble organic compounds
WO1990003782A2 (en) * 1988-10-05 1990-04-19 The Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
DE69112917T2 (de) * 1990-06-15 1996-05-15 Merck & Co Inc Kristallisationsverfahren zur Verbesserung der Kristallstruktur und -grösse.
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5639441A (en) * 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation
SE9501384D0 (sv) 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles

Also Published As

Publication number Publication date
CA2217062A1 (en) 1996-10-17
AU5352496A (en) 1996-10-30
NO316209B1 (no) 2003-12-29
CN1186428A (zh) 1998-07-01
DE69625589D1 (de) 2003-02-06
CN1102383C (zh) 2003-03-05
ES2188750T3 (es) 2003-07-01
DK0820276T3 (da) 2003-03-17
US6221398B1 (en) 2001-04-24
WO1996032095A1 (en) 1996-10-17
SA96160645B1 (ar) 2005-07-05
PT820276E (pt) 2003-04-30
MY117344A (en) 2004-06-30
IL117841A0 (en) 1996-08-04
IN185119B (sv) 2000-11-18
NZ305515A (en) 1999-03-29
NO974557D0 (no) 1997-10-02
DE69625589T2 (de) 2003-09-25
ATE230257T1 (de) 2003-01-15
AR001624A1 (es) 1997-11-26
TW492877B (en) 2002-07-01
EP0820276B1 (en) 2003-01-02
NO974557L (no) 1997-10-02
IL117841A (en) 2004-01-04
AU694863B2 (en) 1998-07-30
JPH11503448A (ja) 1999-03-26
EP0820276A1 (en) 1998-01-28
ZA962596B (en) 1996-10-14

Similar Documents

Publication Publication Date Title
SE9501384D0 (sv) Process for the preparation of respirable particles
BR0317595A (pt) Método e aparelho para produzir partìculas, método para produzir uma mistura de pó seco e composição farmacêutica
CA2335065A1 (en) Pharmaceutical formulations for aerosols with two or more active substances
EA200401006A1 (ru) Аэрозольные препараты для внутрилёгочного введения лекарств с получением системного действия
DE3382587D1 (de) Injizierbares langwirkendes mikroteilchen-praeparat zur verabreichung entzuendungshemmender mittel.
BR9909394A (pt) Composição de aerossol, composição farmacêutica, recipiente, dispositivo de inalação, processo para preparar uma composição de aerossol, mistura de um primeiro material particulado, e, processo para administrar um medicamento particulado
DE60214012D1 (de) Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung
ATE55076T1 (de) Verfahren zur herstellung von titanpulver.
DK32987A (da) Fremgangsmaade og system til liposominhalering
MX9703399A (es) Nanosuspensiones farmaceuticas para la administracion de medicamentos como sistemas de solubilidad de saturacion y velocidad de solucion incrementada.
DE69509671D1 (de) Pharmazeutische zusammensetzung mit einem schmelzbaren traegermaterial und verfahren zu seiner herstellung
CA2170394A1 (en) Process for conditioning substances
HUP0004050A2 (hu) Javított oldódású itrakonazol, eljárás ennek előállítására és ezt tartalmazó orális gyógyszerkészítmény
KR880004806A (ko) 분무 건조 아세트아미노펜
PT1214129E (pt) Processo para a preparacao de substancias medicinais finas
BR0207570A (pt) Aparelho para formação de partìculas micronizadas e submicronizadas de uma substância, bocal para a introdução de uma solução de uma substância e de um fluido supercrìtico em um vaso de formação de partìculas, e, processo para formação de partìculas micronizadas e submicronizadas de uma substância
FR2711523B1 (fr) Procédé de préparation d'un aérosol viral.
CA2339726A1 (en) Smoke-modifying agents and smoking material rods comprising smoke-modifying agents
EP0248362A3 (en) Process for the production of an active protein from a biologically inactive form
FI942222A (sv) Förfarande för framställning av torrbehandlade partiklar, så erhållna torrbehandlade partiklar och farmaceutiska kompositioner innehållande dessa
JPS5225015A (en) Process for preparing fine granular drugs
TH26710A (th) กรรมวิธีสำหรับการเตรียมอนุภาคที่หายใจเข้าไปได้
TH26710B (th) กรรมวิธีสำหรับการเตรียมอนุภาคที่หายใจเข้าไปได้
SE9500251L (sv) Förfarande och aggregat för beredning av en gasblandning avsedd för medicinsk behandling via andningsvägarna
AU6766490A (en) New sulphate derivative of galactan extracted from klebsiella, preparation process, use as medicaments and pharmaceutical compositions containing it